Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.30
CBT's Cash-to-Debt is ranked lower than
78% of the 1137 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.83 vs. CBT: 0.30 )
Ranked among companies with meaningful Cash-to-Debt only.
CBT' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.19 Max: 1.61
Current: 0.3
0.04
1.61
Equity-to-Asset 0.45
CBT's Equity-to-Asset is ranked lower than
69% of the 1096 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. CBT: 0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
CBT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29  Med: 0.42 Max: 0.5
Current: 0.45
0.29
0.5
Debt-to-Equity 0.62
CBT's Debt-to-Equity is ranked lower than
67% of the 867 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.41 vs. CBT: 0.62 )
Ranked among companies with meaningful Debt-to-Equity only.
CBT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.38  Med: 0.6 Max: 1.36
Current: 0.62
0.38
1.36
Debt-to-EBITDA 1.86
CBT's Debt-to-EBITDA is ranked higher than
54% of the 910 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.09 vs. CBT: 1.86 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CBT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -7.04  Med: 2.08 Max: 6.77
Current: 1.86
-7.04
6.77
Interest Coverage 6.34
CBT's Interest Coverage is ranked lower than
76% of the 1020 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 32.34 vs. CBT: 6.34 )
Ranked among companies with meaningful Interest Coverage only.
CBT' s Interest Coverage Range Over the Past 10 Years
Min: 4.32  Med: 5.6 Max: 6.34
Current: 6.34
4.32
6.34
Piotroski F-Score: 8
Altman Z-Score: 3.29
Beneish M-Score: -2.43
WACC vs ROIC
7.69%
14.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 12.37
CBT's Operating Margin % is ranked higher than
72% of the 1114 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.82 vs. CBT: 12.37 )
Ranked among companies with meaningful Operating Margin % only.
CBT' s Operating Margin % Range Over the Past 10 Years
Min: -11.04  Med: 7.79 Max: 12.37
Current: 12.37
-11.04
12.37
Net Margin % 8.87
CBT's Net Margin % is ranked higher than
66% of the 1114 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.78 vs. CBT: 8.87 )
Ranked among companies with meaningful Net Margin % only.
CBT' s Net Margin % Range Over the Past 10 Years
Min: -11.63  Med: 5.57 Max: 11.79
Current: 8.87
-11.63
11.79
ROE % 18.13
CBT's ROE % is ranked higher than
78% of the 1101 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.33 vs. CBT: 18.13 )
Ranked among companies with meaningful ROE % only.
CBT' s ROE % Range Over the Past 10 Years
Min: -21.03  Med: 10.96 Max: 23.52
Current: 18.13
-21.03
23.52
ROA % 7.75
CBT's ROA % is ranked higher than
67% of the 1143 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.81 vs. CBT: 7.75 )
Ranked among companies with meaningful ROA % only.
CBT' s ROA % Range Over the Past 10 Years
Min: -9.33  Med: 4.83 Max: 10.29
Current: 7.75
-9.33
10.29
ROC (Joel Greenblatt) % 19.23
CBT's ROC (Joel Greenblatt) % is ranked higher than
62% of the 1138 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.24 vs. CBT: 19.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CBT' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -15.24  Med: 13.61 Max: 19.23
Current: 19.23
-15.24
19.23
3-Year Revenue Growth Rate -8.20
CBT's 3-Year Revenue Growth Rate is ranked lower than
84% of the 1035 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.50 vs. CBT: -8.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CBT' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -50.2  Med: 4.6 Max: 103.7
Current: -8.2
-50.2
103.7
3-Year EBITDA Growth Rate -3.00
CBT's 3-Year EBITDA Growth Rate is ranked lower than
75% of the 950 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.00 vs. CBT: -3.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CBT' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -53.8  Med: 3.5 Max: 109.4
Current: -3
-53.8
109.4
3-Year EPS without NRI Growth Rate 8.20
CBT's 3-Year EPS without NRI Growth Rate is ranked lower than
68% of the 880 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.70 vs. CBT: 8.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CBT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -22.9  Med: 3.4 Max: 75.2
Current: 8.2
-22.9
75.2
GuruFocus has detected 3 Warning Signs with Cabot Corp CBT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CBT's 30-Y Financials

Financials (Next Earnings Date: 2018-02-01)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

CBT Guru Trades in Q4 2016

Paul Tudor Jones 11,494 sh (+108.56%)
PRIMECAP Management 125,000 sh (unchged)
Chuck Royce 350,400 sh (-3.63%)
Jim Simons 123,500 sh (-40.68%)
Joel Greenblatt 109,932 sh (-65.00%)
» More
Q1 2017

CBT Guru Trades in Q1 2017

Barrow, Hanley, Mewhinney & Strauss 421 sh (New)
Chuck Royce 350,400 sh (unchged)
PRIMECAP Management 125,000 sh (unchged)
Jim Simons Sold Out
Joel Greenblatt 91,485 sh (-16.78%)
Paul Tudor Jones 5,913 sh (-48.56%)
» More
Q2 2017

CBT Guru Trades in Q2 2017

David Dreman 562 sh (New)
Paul Tudor Jones 7,710 sh (+30.39%)
Chuck Royce 350,400 sh (unchged)
Barrow, Hanley, Mewhinney & Strauss 421 sh (unchged)
PRIMECAP Management 125,000 sh (unchged)
Joel Greenblatt 5,603 sh (-93.88%)
» More
Q3 2017

CBT Guru Trades in Q3 2017

Jim Simons 211,200 sh (New)
Steven Cohen 67,000 sh (New)
Paul Tudor Jones 14,267 sh (+85.05%)
David Dreman 562 sh (unchged)
PRIMECAP Management 125,000 sh (unchged)
Barrow, Hanley, Mewhinney & Strauss 421 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 336,207 sh (-4.05%)
» More
» Details

Insider Trades

Latest Guru Trades with CBT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-09-30 Sold Out $51.21 - $56.34 $ 61.0014%0
Joel Greenblatt 2017-06-30 Reduce -93.88%0.07%$50.75 - $60.9 $ 61.0011%5,603
David Dreman 2017-06-30 New Buy0.02%$50.75 - $60.9 $ 61.0011%562
Joel Greenblatt 2017-03-31 Reduce -16.78%0.01%$51.37 - $60.17 $ 61.007%91,485
Barrow, Hanley, Mewhinney & Strauss 2017-03-31 New Buy$51.37 - $60.17 $ 61.007%421
Joel Greenblatt 2016-12-31 Reduce -65.00%0.14%$48.21 - $54.05 $ 61.0018%109,932
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325180    SIC: 2895
Compare:TSE:4088, NYSE:POL, SZSE:000703, OSTO:HPOL B, TSE:4631, NYSE:SXT, BOM:509480, XAMS:IMCD, BOM:500165, TSE:3401, SZSE:002408, TSE:4202, NYSE:KRO, NYSE:PAH, BOM:500870, NYSE:NGVT, NYSE:FUL, SHSE:600873, NYSE:NEU, LSE:VCT » details
Traded in other countries:CBT.Germany,
Headquarter Location:USA
Cabot Corp is a specialty chemicals and performance materials Company. The Company offers rubber and specialty grade carbon blacks, fumed metal oxides, inkjet colorants, aerogel, cesium formate drilling fluids and activated carbon.

Cabot Corp is a specialty chemicals and performance materials Company. The Company offers rubber and specialty grade carbon blacks, fumed metal oxides, inkjet colorants, aerogel, cesium formate drilling fluids and activated carbon.

Ratios

vs
industry
vs
history
PE Ratio 16.00
CBT's PE Ratio is ranked higher than
62% of the 943 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.43 vs. CBT: 16.00 )
Ranked among companies with meaningful PE Ratio only.
CBT' s PE Ratio Range Over the Past 10 Years
Min: 5.63  Med: 16.63 Max: 45.83
Current: 16
5.63
45.83
Forward PE Ratio 16.08
CBT's Forward PE Ratio is ranked higher than
71% of the 96 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 17.30 vs. CBT: 16.08 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 16.00
CBT's PE Ratio without NRI is ranked higher than
63% of the 943 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.62 vs. CBT: 16.00 )
Ranked among companies with meaningful PE Ratio without NRI only.
CBT' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.95  Med: 17.34 Max: 45.19
Current: 16
8.95
45.19
Price-to-Owner-Earnings 20.90
CBT's Price-to-Owner-Earnings is ranked lower than
63% of the 512 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 24.00 vs. CBT: 20.90 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CBT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.11  Med: 15.23 Max: 592.08
Current: 20.9
2.11
592.08
PB Ratio 2.55
CBT's PB Ratio is ranked lower than
59% of the 1099 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.00 vs. CBT: 2.55 )
Ranked among companies with meaningful PB Ratio only.
CBT' s PB Ratio Range Over the Past 10 Years
Min: 0.47  Med: 1.64 Max: 3.07
Current: 2.55
0.47
3.07
PS Ratio 1.41
CBT's PS Ratio is ranked higher than
51% of the 1095 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.38 vs. CBT: 1.41 )
Ranked among companies with meaningful PS Ratio only.
CBT' s PS Ratio Range Over the Past 10 Years
Min: 0.19  Med: 0.83 Max: 1.52
Current: 1.41
0.19
1.52
Price-to-Free-Cash-Flow 19.80
CBT's Price-to-Free-Cash-Flow is ranked lower than
54% of the 359 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.81 vs. CBT: 19.80 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CBT' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.13  Med: 14.02 Max: 75.4
Current: 19.8
2.13
75.4
Price-to-Operating-Cash-Flow 11.22
CBT's Price-to-Operating-Cash-Flow is ranked lower than
55% of the 469 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.23 vs. CBT: 11.22 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CBT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.23  Med: 8.01 Max: 18.17
Current: 11.22
1.23
18.17
EV-to-EBIT 13.30
CBT's EV-to-EBIT is ranked higher than
60% of the 969 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.64 vs. CBT: 13.30 )
Ranked among companies with meaningful EV-to-EBIT only.
CBT' s EV-to-EBIT Range Over the Past 10 Years
Min: -78.6  Med: 13.6 Max: 1630.6
Current: 13.3
-78.6
1630.6
EV-to-EBITDA 9.14
CBT's EV-to-EBITDA is ranked higher than
68% of the 994 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.33 vs. CBT: 9.14 )
Ranked among companies with meaningful EV-to-EBITDA only.
CBT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -36.7  Med: 8.6 Max: 20.2
Current: 9.14
-36.7
20.2
EV-to-Revenue 1.67
CBT's EV-to-Revenue is ranked lower than
53% of the 1104 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.54 vs. CBT: 1.67 )
Ranked among companies with meaningful EV-to-Revenue only.
CBT' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.4  Med: 1.1 Max: 1.9
Current: 1.67
0.4
1.9
Shiller PE Ratio 30.98
CBT's Shiller PE Ratio is ranked higher than
52% of the 271 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 30.43 vs. CBT: 30.98 )
Ranked among companies with meaningful Shiller PE Ratio only.
CBT' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.55  Med: 22.52 Max: 35.43
Current: 30.98
4.55
35.43
Current Ratio 1.70
CBT's Current Ratio is ranked lower than
58% of the 1015 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.90 vs. CBT: 1.70 )
Ranked among companies with meaningful Current Ratio only.
CBT' s Current Ratio Range Over the Past 10 Years
Min: 0.99  Med: 1.97 Max: 3.35
Current: 1.7
0.99
3.35
Quick Ratio 1.17
CBT's Quick Ratio is ranked lower than
61% of the 1015 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.38 vs. CBT: 1.17 )
Ranked among companies with meaningful Quick Ratio only.
CBT' s Quick Ratio Range Over the Past 10 Years
Min: 0.61  Med: 1.3 Max: 2.35
Current: 1.17
0.61
2.35
Days Inventory 66.85
CBT's Days Inventory is ranked lower than
52% of the 1075 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 66.54 vs. CBT: 66.85 )
Ranked among companies with meaningful Days Inventory only.
CBT' s Days Inventory Range Over the Past 10 Years
Min: 50.22  Med: 64.47 Max: 79.75
Current: 66.85
50.22
79.75
Days Sales Outstanding 70.80
CBT's Days Sales Outstanding is ranked lower than
60% of the 922 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 62.94 vs. CBT: 70.80 )
Ranked among companies with meaningful Days Sales Outstanding only.
CBT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 60.64  Med: 71.69 Max: 77.54
Current: 70.8
60.64
77.54

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.01
CBT's Dividend Yield % is ranked higher than
70% of the 1160 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.77 vs. CBT: 2.01 )
Ranked among companies with meaningful Dividend Yield % only.
CBT' s Dividend Yield % Range Over the Past 10 Years
Min: 1.35  Med: 2.07 Max: 8.83
Current: 2.01
1.35
8.83
Dividend Payout Ratio 0.34
CBT's Dividend Payout Ratio is ranked lower than
58% of the 779 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.30 vs. CBT: 0.34 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CBT' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.33 Max: 0.54
Current: 0.34
0.26
0.54
3-Year Dividend Growth Rate 13.60
CBT's 3-Year Dividend Growth Rate is ranked higher than
57% of the 552 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.30 vs. CBT: 13.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CBT' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -0.1  Med: 5 Max: 14.6
Current: 13.6
-0.1
14.6
Forward Dividend Yield % 2.06
CBT's Forward Dividend Yield % is ranked higher than
64% of the 1118 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.87 vs. CBT: 2.06 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.19
CBT's 5-Year Yield-on-Cost % is ranked higher than
70% of the 1388 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.12 vs. CBT: 3.19 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CBT' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.14  Med: 3.29 Max: 14.03
Current: 3.19
2.14
14.03
3-Year Average Share Buyback Ratio 1.30
CBT's 3-Year Average Share Buyback Ratio is ranked higher than
89% of the 592 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -2.60 vs. CBT: 1.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CBT' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.2  Med: 0.8 Max: 18.5
Current: 1.3
-1.2
18.5

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 3.17
CBT's Price-to-Tangible-Book is ranked lower than
64% of the 1055 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.18 vs. CBT: 3.17 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CBT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.01  Med: 1.77 Max: 3.32
Current: 3.17
1.01
3.32
Price-to-Intrinsic-Value-Projected-FCF 1.20
CBT's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
63% of the 528 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.56 vs. CBT: 1.20 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CBT' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.75  Med: 1.24 Max: 3.44
Current: 1.2
0.75
3.44
Price-to-Median-PS-Value 1.70
CBT's Price-to-Median-PS-Value is ranked lower than
65% of the 1005 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.29 vs. CBT: 1.70 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CBT' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.26  Med: 0.87 Max: 2.1
Current: 1.7
0.26
2.1
Price-to-Peter-Lynch-Fair-Value 2.20
CBT's Price-to-Peter-Lynch-Fair-Value is ranked lower than
99.99% of the 319 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.19 vs. CBT: 2.20 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CBT' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0  Med: 1.01 Max: 4.15
Current: 2.2
0
4.15
Price-to-Graham-Number 1.50
CBT's Price-to-Graham-Number is ranked higher than
50% of the 797 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.47 vs. CBT: 1.50 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CBT' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.54  Med: 1.06 Max: 1.82
Current: 1.5
0.54
1.82
Earnings Yield (Greenblatt) % 7.50
CBT's Earnings Yield (Greenblatt) % is ranked higher than
66% of the 1141 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.02 vs. CBT: 7.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CBT' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -11.5  Med: 6.7 Max: 11.2
Current: 7.5
-11.5
11.2
Forward Rate of Return (Yacktman) % 15.46
CBT's Forward Rate of Return (Yacktman) % is ranked higher than
67% of the 645 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 9.25 vs. CBT: 15.46 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CBT' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -14.7  Med: 14.35 Max: 34.6
Current: 15.46
-14.7
34.6

More Statistics

Revenue (TTM) (Mil) $2,717.00
EPS (TTM) $ 3.81
Beta1.00
Short Percentage of Float1.69%
52-Week Range $50.21 - 64.66
Shares Outstanding (Mil)61.88

Analyst Estimate

Sep18 Sep19 Sep20
Revenue (Mil $) 2,888 2,975 3,064
EPS ($) 3.81 4.10 4.40
EPS without NRI ($) 3.81 4.10 4.40
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 88
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}